Intrinsic Value

Mersana Therapeutics, Inc. (MRSN)

$3.25

-0.09 (-2.69%)

Enterprise Value -17,528,333,008,259,372
Net Debt -140.73
Equity Value -17,528,333,008,259,232
Shares Outstanding 116.11
Equity Value Per Share -150,959,405,603,459.06



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt